The potential use of ebselen in treatment-resistant depression

The potential use of ebselen in treatment-resistant depression

Ebselen is an organoselenium compound developed as an antioxidant and subsequently shown to be a glutathione peroxidase (GPx) mimetic. Ebselen shows some efficacy in post-stroke neuroprotection and is currently in trial for the treatment and prevention of hearing loss, Meniere’s Disease and severe a...

Полное описание

Библиографические подробности
Главные авторы:	Ramli, FF, Cowen, PJ, Godlewska, BR
Формат:	Journal article
Язык:	English
Опубликовано:	MDPI 2022

Схожие документы

The Potential Use of Ebselen in Treatment-Resistant Depression
по: Fitri Fareez Ramli, и др.
Опубликовано: (2022-04-01)

Effects of ebselen addition on emotional processing and brain neurochemistry in depressed patients unresponsive to antidepressant medication
по: Ramli, FF, и др.
Опубликовано: (2024)

Investigating the effects of the lithium-mimetic drug, ebselen, on emotional processing and brain neurochemistry in patients with medication-resistant depression
по: Ramli, FF
Опубликовано: (2024)

Effects of the potential lithium-mimetic, ebselen, on impulsivity and emotional processing
по: Masaki, C, и др.
Опубликовано: (2016)

Effects of ebselen addition on emotional processing and brain neurochemistry in depressed patients unresponsive to antidepressant medication
по: Fitri Fareez Ramli, и др.
Опубликовано: (2024-05-01)

Behavioural characterisation of ebselen; a potential lithium-mimetic
по: Singh, N, и др.
Опубликовано: (2014)

Effects of the potential lithium-mimetic, ebselen, on brain neurochemistry: a magnetic resonance spectroscopy study at 7 tesla
по: Masaki, C, и др.
Опубликовано: (2016)

Ebselen as a novel IMPase inhibitor as a lithium mimetic
по: Churchill, G, и др.
Опубликовано: (2014)

The putative lithium-mimetic ebselen reduces impulsivity in rodent models
по: Barkus, C, и др.
Опубликовано: (2018)

Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens.
по: Shankar Thangamani, и др.
Опубликовано: (2015-01-01)

Stress, inflammation and hippocampal subfields in depression: A 7 tesla MRI study
по: Tannous, J, и др.
Опубликовано: (2020)

Translating the promise of 5HT4 receptor agonists for the treatment of depression
по: Murphy, SE, и др.
Опубликовано: (2020)

Investigating the neurochemistry of depression and the novel mood stabilising agent, ebselen, using magnetic resonance spectroscopy
по: Masaki, C
Опубликовано: (2016)

Ebselen Optimized the Therapeutic Effects of Silver Nanoparticles for Periodontal Treatment
по: Liang Y, и др.
Опубликовано: (2023-12-01)

Predicting treatment response in depression: the role of anterior cingulate cortex
по: Godlewska, BR, и др.
Опубликовано: (2018)

Is Ebselen A Therapeutic Target in Fracture Healing?
по: Ahmet Kose, и др.
Опубликовано: (2020-06-01)

Chemistry Related to the Catalytic Cycle of the Antioxidant Ebselen
по: Kai N. Sands, и др.
Опубликовано: (2023-04-01)

Ebselen: A Promising Repurposing Drug to Treat Infections Caused by Multidrug-Resistant Microorganisms
по: Agostinho Alves de Lima e Silva, и др.
Опубликовано: (2024-01-01)

Ebselen and Analogues: Pharmacological Properties and Synthetic Strategies for Their Preparation
по: Claudio Santi, и др.
Опубликовано: (2021-07-01)

Ebselen Interferes with Alzheimer’s Disease by Regulating Mitochondrial Function
по: Xuexia Li, и др.
Опубликовано: (2022-07-01)

Convergent Synthesis of Two Fluorescent Ebselen-Coumarin Heterodimers
по: Jim Küppers, и др.
Опубликовано: (2016-07-01)

Effect of the putative lithium mimetic ebselen on brain myo-inositol, sleep, and emotional processing in humans
по: Singh, N, и др.
Опубликовано: (2016)

Effect of the Putative Lithium Mimetic Ebselen on Brain Myo-Inositol, Sleep, and Emotional Processing in Humans
по: Singh, N, и др.
Опубликовано: (2015)

Cognitive neuropsychological theory of antidepressant action: A modern-day approach to depression and its treatment
по: Godlewska, BR, и др.
Опубликовано: (2020)

Synergistic antibacterial effect of silver and ebselen against multidrug‐resistant Gram‐negative bacterial infections
по: Lili Zou, и др.
Опубликовано: (2017-06-01)

Metallocenyl derivatives of ebselen are selective and competitive inhibitors of thioredoxin reductase
по: Koh, Wei Xiang, и др.
Опубликовано: (2022)

The Effectiveness of Ebselen in Facial Nerve Crush Injury: An Experimental Study
по: Lütfü Şeneldir, и др.
Опубликовано: (2024-11-01)

In Vitro Anti-Prostate Cancer Activity of Two Ebselen Analogues
по: Katarzyna B. Kaczor-Keller, и др.
Опубликовано: (2020-03-01)

Neurochemistry of major depression: a study using magnetic resonance spectroscopy.
по: Godlewska, B, и др.
Опубликовано: (2015)

In Vitro Efficacy of Ebselen and BAY 11-7082 Against Naegleria fowleri
по: Anjan Debnath, и др.
Опубликовано: (2018-03-01)

The Assessment on Synergistic Activity of Ebselen and Silver Ion Against Yersinia pseudotuberculosis
по: Chuanjiang Dong, и др.
Опубликовано: (2022-07-01)

Synthesis of new alkylated and methoxylated analogues of ebselen with antiviral and antimicrobial properties
по: Magdalena Piętka-Ottlik, и др.
Опубликовано: (2017-02-01)

Developing selective histone deacetylases (HDACs) inhibitors through ebselen and analogs
по: Wang Y, и др.
Опубликовано: (2017-05-01)

Investigation of the neurochemical, molecular and behavioural properties of the putative lithium-mimetic, ebselen
по: Antoniadou, I
Опубликовано: (2015)

Use of ebselen as a neuroprotective agent in rat spinal cord subjected to traumatic injury
по: Wojciech Slusarczyk, и др.
Опубликовано: (2019-01-01)

Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients.
по: Godlewska, B, и др.
Опубликовано: (2012)

Short-term SSRI treatment remediates amygdala hyperactivity in depressed patients
по: Godlewska, B, и др.
Опубликовано: (2011)

Topical Therapeutic Efficacy of Ebselen Against Multidrug-Resistant Staphylococcus aureus LT-1 Targeting Thioredoxin Reductase
по: Chuanjiang Dong, и др.
Опубликовано: (2020-01-01)

Drug treatment of tricyclic resistant depression
по: Chalmers, J, и др.
Опубликовано: (1990)

The Clinical Drug Ebselen Attenuates Inflammation and Promotes Microbiome Recovery in Mice after Antibiotic Treatment for CDI
по: Megan Garland, и др.
Опубликовано: (2020-04-01)